Full Length Research Paper
References
|
Alviano DS, Alviano CS (2009). Plant extracts: Search for new alternatives to treat microbial diseases. Curr. Pharm. Biotech. 10(1):106-121. |
|
|
Amyes SGB, Walsh FM, Bradley JS (2007). Best in class: A good principle for antibiotic usage to limit resistance development? J. Antimicrob. Chemother. 59(5):825-826. |
|
|
Andrews JM (2001). Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(SUPPL. 1): 5-16. |
|
|
Arora S, Baptista C, Lim CS (2011). Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Ann. Clin. Microbiol. Antimicrob. 10(1).1-6 |
|
|
Arora S, Lim CS, Foo JY, Sakharkar MK, Dixit P, Liu AQ, Miao JM (2009). Microchip system for monitoring microbial physiological behaviour under drug influences. Proceedings of the Institution of Mechanical Engineers, Part H: J. Eng. Med. 223(6):777-786. |
|
|
Barrett JF (2005). Can biotech deliver new antibiotics? Curr. Opin. Microbiol. 8(5):498-503. |
|
|
Bax R, Mullan N, Verhoef J (2000). The millennium bugs - The need for and development of new antibacterials. Int. J. Antimicrob. Agents. 16(1): 51-59. |
|
|
Bearden DT, Danziger LH (2001). Mechanism of action of and resistance to quinolones. Pharmacotherapy. 21(10 II SUPPL.). Bernard FX, Sable S, Cameron B, Provost J, Desnottes JF, Crouzet J, topoisomerase IV. Antimicrob. Agents Chemother. 41(5):992-998. |
|
|
Campion JJ, McNamara PJ, Evans ME (2004). Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments. Antimicrob. Agents Chemother. 48(12):4733-4744. |
|
|
Cottarel G, Wierzbowski J (2007). Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol. 25(12):547-555. |
|
|
Cowan MM (1999). Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12(4):564-582. |
|
|
Cragg GM, Newman DJ (2005). Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100(1-2):72-79. |
|
|
Cushnie TPT, Lamb AJ (2005). Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents. 26(5):343-356. |
|
|
Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, Bielenberg J (2008). Antiviral effects of Glycyrrhiza species. Phytother. Res. 22(2):141-148. |
|
|
Gibbons S (2004). Anti-staphylococcal plant natural products. Nat. Prod. Rep. 21(2):263-277. |
|
|
Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006). Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 368(9538):874-885. |
|
|
Hilliard JJ, Krause HM, Bernstein JI, Fernandez JA, Nguyen V, Ohemeng KA, Barrett JF (1996). A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase. Adv. Exp. Med. Biol. 390:59-70. |
|
|
Hooper DC (2002). Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2(9):530-538. |
|
|
Kubo I, Fujita KI, Nihei KI (2002). Anti-Salmonella activity of alkyl gallates. J. Agric. Food Chem. 50(23):6692-6696. |
|
|
Kubo I, Fujita KI, Nihei KI (2003). Molecular design of multifunctional antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA). Bioorg. Med. Chem. 11(19):4255-4262. |
|
|
Kyaw BM, Arora S, Win KN, Danie LCS (2011). Prevention of emergence of fusidic acid and rifampicin resistance in Staphylococcus aureus using phytochemicals. Afr. J. Microbiol. Res. 5(22):3684-3692. |
|
|
Levy SB, Marshall B (2004). Antibacterial resistance worldwide: Causes, challenges and responses. Nat. Med. 10(S12):S122-S129. |
|
|
Lewis K, Ausubel FM (2006). Prospects for plant-derived antibacterials. Nat. Biotechnol. 24(12):1504-1507. |
|
|
Lindsay JA, Holden MTG (2004). Staphylococcus aureus: Superbug, super genome? Trends Microbiol. 12(8):378-385. |
|
|
Liu KS, Tsao SM, Yin MC (2005). In vitro antibacterial activity of roselle calyx and protocatechuic acid. Phytother. Res. 19(11): 942-945. |
|
|
Livermore DM (2000). Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents. 16(S1):S3-S10. |
|
|
Lorian V (2005). Antibiotics in Laboratory Medicine PA 19106, Lippincott William and Wilkins. |
|
|
Marquez B, Neuville L, Moreau NJ, Genet JP, Dos Santos AF, De Andrade MCC, Sant'Ana AEG (2005). Multidrug resistance reversal agent from Jatropha elliptica. Phytochemistry. 66(15):1804-1811. |
|
|
Mirzoeva OK, Grishanin RN, Calder PC (1997). Antimicrobial action of propolis and some of its components: The effects on growth, membrane potential and motility of bacteria. Microbiol. Res. 152(3):239-246. |
|
|
Moellering RC (1983). Rationale for use of antimicrobial combinations. Am. J. Med. 75(2 A):4-8. |
|
|
Nakanishi N, Yoshida S, Wakebe H, Inoue M, Yamaguchi T, Mitsuhashi S (1991). Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 35(12):2562-2567. |
|
|
Norrby SR, Nord CE, Finch R (2005). Lack of development of new antimicrobial drugs: A potential serious threat to public health. Lancet Infect. Dis. 5(2):115-119. |
|
|
Pillai SK, Moellering RCJ, Eliopoulos GM (2005). Antimicrobial Combinations. Antibiotics in Laboratory Medicine. Lorian V, Lippincott Williams and Wilkins. pp. 365-440. |
|
|
Plaper A, Golob M, Hafner I, Oblak M, Å olmajer T, Jerala R (2003). Characterization of quercetin binding site on DNA gyrase. Biochem. Biophys. Res. Commun. 306(2):530-536. |
|
|
Rahman MM, Lopa SS, Sadik G, Harun Or R, Islam R, Khondkar P, Alam AHMK, Rashid MA (2005). Antibacterial and cytotoxic compounds from the bark of Cananga odorata. Fitoterapia. 76(7-8):758-761. |
|
|
Raos JL, Recio MC (2005). Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 100(1-2): 80-84. |
|
|
Sakharkar MK, Jayaraman P, Soe WM, Chow VTK, Sing LC, Sakharkar KR (2009). In vitro activity of antibiotics and phytochemicals against Pseudomonas aeruginosa. J. Microbiol. Immunol. Infect. 42(5):364-370. |
|
|
Sarris J (2007). Herbal medicines in the treatment of psychiatric disorders: A systematic review. Phytother. Res. 21(8):703-716. |
|
|
Schwalbe R, Steele-Moore L, Goodwin AC (2007). Antimicrobial Susceptibility Testing Protocols, CRC Press, Taylor and Francis Group. |
|
|
Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, Takaishi Y, Arakaki N, Higuti T (2005). Alkyl gallates, intensifiers of B-lactam susceptibility in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49(2):549-555. |
|
|
Sibanda T, Okoh AI (2007). The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr J Biotechnol. 6(25): 2886-2896. |
|
|
Simoes M, Bennett RN and Rosa EA (2009). Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat. Prod. Rep. 26(6):746-757. |
|
|
Standards NCCL (1992). Methods for determining bactericidal activity of antimicrobial agents. National Committee for Clinical Laboratory Standards: M26-T. |
|
|
Standards NCCL (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, National Committee for Clinical Laboratory Standards: M7-A5. |
|
|
Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JMT, Taylor PW (2004a). Modulation of B-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents. 23(5):462-467. |
|
|
Stapleton PD, Shah S, Hamilton-Miller JMT, Hara Y, Nagaoka Y, Kumagai A, Uesato S, Taylor PW (2004b). Anti-Staphylococcus aureus activity and oxacillin resistance modulating capacity of 3-O-acyl-catechins. Int. J. Antimicrob. Agents. 24(4):374-380. |
|
|
Sutandar A, Lim CS, Hsu LY (2008). System for real-time monitoring of mutation-in-progress. J. Appl. Microbiol. 104(5):1400-1407. |
|
|
Tegos G, Stermitz FR, Lomovskaya O, Lewis K (2002). Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46(10):3133-3141. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
